Clinical Trials for Pancreatic Cancer
Impossible d'ajouter des articles
Échec de l’élimination de la liste d'envies.
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
Clinical Trials for Pancreatic Cancer
-
Lu par :
-
De :
À propos de ce contenu audio
How do doctors decide when to use standard chemotherapy, explore immunotherapy, or recommend a clinical trial? In this episode of PancChat, host Alisyn Camerota speaks with Dr. Andrew Hendifar about how tumor sequencing, genetic testing, and emerging KRAS-targeted therapies are reshaping pancreatic cancer care. They discuss the challenges patients face navigating clinical trials, why timing and advocacy are critical, and why — despite the daunting diagnosis — there’s more reason for hope today than ever before.
Dr. Andrew Hendifar heads the Gastrointestinal Disease Research Group and founded their Hematology and Oncology Fellowship Program at Cedars-Sinai Medical Center in Los Angeles. He works with SWOG and the NIH’s Neuroendocrine Tumor Task Force., Dr. Hendifar is a member of PanCAN’s Scientific and Medical Advisory Board.
Learn more about how clinical trials work on the Let’s Win What Is a Clinical Trial? Page or PanCAN’s Clinical Trials page.
You can explore available clinical trials through the Let’s Win’s Trial Finder or the PanCAN Clinical Trial Finder.
For a personalized search, PanCAN’s Patient Services is also here to help.
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !
